Skip to main content
Health

The Confederation of Respiratory Critical Care Trials (CoReCCT)

Acute respiratory failure is a common, life-threating condition associated with significant morbidity and mortality. It is a common indication for intensive care admission and frequently requires invasive or non-invasive mechanical ventilatory support. In the UK, over 60,000 adults each year receive invasive ventilation in an intensive care unit (ICU). Whilst this is a life-saving intervention, patients often experience short-term consequences including worsening lung function, hospital acquired infection and death. They also experience long-term physical, psychological and social impacts on their lives. There is an urgent need to identify innovative ventilation strategies that can be implemented easily and quickly to reduce the need for intubation and the duration of mechanical ventilation.

Aims

The primary aim of the Confederation of Critical Care Trials (CoReCCT) group is to gain efficiency in the management of acute respiratory failure trials co-enrolling in the same or similar patient populations. The primary aim of the clinical trials (domains) outlined in the CoReCCT master protocol, is to test the clinical and cost effectiveness of interventional strategies on patient outcomes in hospitalised adults with moderate-severe acute respiratory failure that require oxygen support or tracheal intubation and invasive mechanical ventilation.

The four trials within CoReCCT are:

Project status: Ongoing
Picture1

Principal Investigators

Investigators

Funding

Funding Body: National Institute for Health and Care Research

Amount: .

Period: January 2024 - December 2027

Contact us

Professor Louise Rose is a Co-Investigator and Process Evaluation Lead.

Keywords

AWAKE PRONERELEASEPROTECT AIRWAYSNAVAUKNAVACORECCTCONFEDERATIONCRITICAL CAREINTENSIVE CAREICUCCURESPIRATORYAPRVAIRWAY PRESSURE RELEASE VENTILATIONVENTILATIONVENTILATORAHRFARDS